Senior Consultant, CMC Development and Manufacturing

Gen Edit is a rapidly-growing, early-stage company that is developing a proprietary and novel delivery platform with the potential to transform genetic medicine. Our interdisciplinary team works together across chemistry, payload design, formulation, and screening and preclinical groups to develop the next generation of gene therapies. Gen Edit fosters an exciting and dynamic environment where we value impactful data and creative solutions to accelerate our progression from a platform technology to a pipeline of therapeutic candidates.

We are seeking talented and motivated individuals to join our team and are expanding across all functions within the organization. Join us in South San Francisco, CA, to be at the forefront of the future of gene therapy.

Gen Edit is looking for an individual who will provide technical and organizational leadership and work closely with cross‑functional stakeholders to ensure CMC activities are executed seamlessly and in alignment with the integrated product development plan and program timelines. The individual will lead the management of manufacturing of established drug substances and drug products for late‑phase clinical trials and the development of new products.

The individual will also contribute to the overall CMC strategy, planning, and execution; provide regulatory documentation for all phases of clinical trials and commercialization; and play a role in CDMO management for other CMC areas including analytical and drug product.

The senior consultant will be a contributing member of the R&D management team to plan and execute on company objectives and R&D strategy for all programs. This person must be a strong scientist with a sound track record of technical expertise and organizational leadership, early and late stage CMC and a knowledge of the drug discovery process from exploratory research to IND submission.

This person must be able to guide and drive project teams to make decisions and recommendations to the executive team, is a critical and creative problem solver, and comfortable in a dynamic, start‑up environment to find solutions to scientific, technical, and resource allocation issues to move programs forward. The ideal candidate will be a team player with excellent communications skills and work collaboratively across all functions within the company and with external partners.

• Key polymer synthesis and development and manufacturing operations to maintain and advance company pipeline.
• Manage and maintain project timelines for CMC activities in support of early and late‑phase clinical trials, ensuring strategy and roadmaps align with and feed into company goals and project timelines.
• Manage in‑house CMC personnel and external subject matter experts.
• Lead CDMO and other vendor identification, assessment, qualification, and management with adequate risk assessment.
• Manage tech transfer, process familiarization, and manufacturing at CDMOs to ensure timely delivery of GMP drug substance and drug product.
• Contract and Quality Agreement negotiation.
• Develop and carry‑out a QBD approach to identify CPPs in support of CQAs for efficacy and safety of drug substance.
• Author, review, and approve the relevant CMC sections to enable global regulatory filings.
• Generate, review, and/or approve study protocols, development reports, and manufacturing batch records.
• Manage developmental stage‑appropriate analytical activities.
• Communicate CMC strategy and project status to key stakeholders cross‑functionally and assist in driving decision‑making.
• Collaborate with cross‑functional teams (clinical development, clinical operations, regulatory affairs, quality, IP) to ensure CMC and program goals are met.

• PhD in polymer chemistry or polymer science and engineering with industry experience in synthesis scale‑up and downstream processing, ideally in a therapeutic drug context.
• 10+ years in industry CMC; 3+ years of experience as CMC team leader, managing team members and projects.
• Proven success in vendor management, specifically CDMOs, with track record of negotiating contracts and…